Nonetheless, a better understanding of the intricate molecular mechanisms involved in HER2-altered cancer cells in relation to tumor progression, angiogenesis, immune escape and treatment resistance is still necessary to develop even more efficient therapeutic strategies. This evidence concerns the gene ERBB2 and cancer.